Clinical, Pathological, and Biochemical Spectrum of Alzheimer Disease Associated with PS-1 Mutations

American Journal of Geriatric Psychiatry

Volumn 12, Issue 2, 2004, Pages 146-156

  Lleó, Alberto ^a   Berezovska, Oksana ^a   Growdon, John H ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 14; CLINICAL FEATURE; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC HETEROGENEITY; HEREDITY; HUMAN; NEUROFIBRILLARY TANGLE; PHENOTYPE; REVIEW;

EID: 1342344129     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200403000-00006     Document Type: Article

References (127)

1. Campion D, Dumanchin C, Hannequin D, et al: Early-onset autosomal-dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 1999; 65:664-670
2. Cruts M, van Duijn CM, Backhovens H, et al: Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7:43-51
3. Goate A, Chartier-Harlin MC, Mullan M, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349:704-707
4. Sherrington R, Rogaev EI, Lyang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760
5. Levy-Lahad E, Wasco W, Poorkaj P, et al: Candidate gene for the Chromosome 1 familial Alzheimer's disease locus. Science 1995; 269:973-977
6. Rogaev EI, Sherrington R, Rogaeva EA, et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on Chromosome 1 related to the Alzheimer's disease Type 3 gene. Nature 1995; 376:775-778
7. Sherrington R, Froelich S, Sorbi S, et al: Alzheimer's disease associated with mutations in presenilin-2 is rare and variably penetrant. Hum Mol Genet 1996; 5:985-988
8. Tanzi RE, Vaula G, Romano DM, et al: Assessment of amyloid β-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet 1992; 1:273-282
9. Lleó A, Blesa R, Queralt R, et al: Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer's disease in Spain. Arch Neurol 2002; 59:1759-1763
10. Janssen JC, Beck JA, Campbell TA, et al: Early-onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology 2003; 60:235-239
11. Cruts M, Van Broeckhoven C: Molecular genetics of Alzheimer's disease, in The Dementias. Edited by Growdon JH, Rossor M. Woburn, MA, Butterworth-Heinemann, 1998, pp 155-170
12. Gomez-Isla T, Growdon WB, McNamara MJ, et al: The impact of different presenilin-1 and presenilin-2 mutations on amyloid deposition, neurofibrillary changes, and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain 1999; 122:1709-1719
13. Lippa CF, Swearer JM, Kane KJ, et al: Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol 2000; 48:376-379
14. Scheuner D, Eckman C, Jensen M, et al: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin-1 and -2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996; 2:864-870
15. Mehta ND, Refolo LM, Eckman C, et al: Increased ABeta42(43) from cell lines expressing presenilin-1 mutations. Ann Neurol 1998; 43:256-258
16. Duff K, Eckman C, Zehr C, et al: Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin-1. Nature 1996; 383:710-713
17. Citron M, Westaway D, Xia W, et al: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 1997; 3:67-72
18. St. George-Hyslop P, Haines JL, Farrer LA, et al: Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature 1990; 347:194-197
19. Schellenberg G, Bird T, Wijsman EM, et al: Genetic linkage evidence for a familial Alzheimer's disease locus on Chromosome 14. Science 1992; 258:668-671
20. Van Broeckhoven C, Backhovens H, Cruts M, et al: Mapping of a gene predisposing to early-onset Alzheimer's disease to Chromosome 14q24.3. Nat Genet 1992; 2:335-339
21. St. George-Hyslop P, Haines JL, Rogaev E, et al: Genetic evidence for a novel familial Alzheimer's disease locus on Chromosome 14. Nat Genet 1992; 2:330-334
22. Mullan M, Houlden H, Windelspecht M, et al: A locus for Alzheimer's disease on the long arm of Chromosome 14, proximal to the a1-antichymotrypsin gene. Nat Genet 1992; 2:340-342
23. Kovacs DM, Fausett HJ, Page KJ, et al: Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 1996; 2:224-229
24. Li X, Greenwald I. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc Natl Acad Sci U S A 1998; 95:7109-7114
25. Thinakaran G, Borchelt DR, Lee MK, et al: Endoproteolysis of presenilin-1 and accumulation of processed derivatives in vivo. Neuron 1996; 17:181-190
26. Crook R, Ellis R, Shanks M, et al: Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Ann Neurol 1997; 42:124-128
27. Hardy J, Crook R: Presenilin mutations line up along transmembrane alpha-helices. Neurosci Lett 2001; 306:203-205
28. Queralt R, Ezquerra M, Lleó A, et al: A novel mutation (V89L) in the presenilin-1 gene in a family with early-onset Alzheimer's disease and marked behavioral disturbances. J Neurol Neurosurg Psychiatry 2002; 72:266-269
29. Prihar G, Gonzalez de Chavez F, Baker M, et al: A novel candidate presenilin-1-interacting protein containing tetratricopeptide repeats. Neuroreport 1999; 10:1409-1415
30. Crook R, Verkkoniemi A, Perez-Tur J, et al: A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin-1. Nat Med 1998; 4:452-455
31. Smith MJ, Kwok JB, McLean CA, et al: Variable phenotype of Alzheimer's disease with spastic paraparesis. Ann Neurol 2001; 49:125-129
32. Houlden H, Baker M, McGowan E, et al: Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 2000; 48:806-808
33. Perez-Tur J, Froelich S, Prihar G, et al: A mutation in Alzheimer's disease destroying a splice-acceptor site in the presenilin-1 gene. Neuroreport 1995; 7:297-301
34. Ishii K, Ii K, Hasegawa T, et al: Increased ABeta42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. Neurosci Lett 1997; 228:17-20
35. Sato S, Kamino K, Miki T, et al: Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease. Hum Mutat 1998; suppl:S91-S94
36. De Jonghe C, Cruts M, Rogaeva EA, et al: Aberrant splicing in the presenilin-1 intron-4 mutation causes presenile Alzheimer's disease by increased ABeta42 secretion. Hum Mol Genet 1999; 8:1529-1540
37. Rogaeva EA, Fafel KC, Song YQ, et al: Screening for PS-1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 2001; 57:621-625
38. Moehlmann T, Winkler E, Xia X, et al: Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on ABeta42 production. Proc Natl Acad Sci U S A 2002; 99:8025-8030
39. Axelman K, Basun H, Lannfelt L: Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch Neurol 1998; 55:698-702
40. Janssen JC, Lantos PL, Fox NC, et al: Autopsy-confirmed familial early-onset Alzheimer disease caused by the 1153V presenilin-1 mutation. Arch Neurol 2001; 58:953-958
41. Fox NC, Kennedy AM, Harvey RJ, et al: Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin-1 gene: pedigree but not mutation-specific age at onset provides evidence for a further genetic factor. Brain 1997; 120:491-501
42. Lopera F, Ardilla A, Martinez A, et al: Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997; 277:793-799
43. Rossor MN, Fox NC, Beck J, et al: Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 1996; 347:1560
44. Poorkaj P, Sharma V, Anderson L, et al: Missense mutations in the Chromosome 14 familial Alzheimer's disease presenilin-1 gene. Hum Mutat 1998; 11:216-221
45. Levy-Lahad E, Lahad A, Wijsman EM, et al: Apolipoprotein-E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995; 38:678-680
46. Romero I, Jorgensen P, Bolwig G, et al: A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease. Neuroreport 1999; 10:2255-2260
47. Kwok JB, Taddei K, Hallupp M, et al: Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 1997; 8:1537-1542
48. Lampe TH, Bird TD, Nochlin D, et al: Phenotype of Chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994; 36:368-378
49. Haltia M, Viitanen M, Sulkava R, et al: Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 1994; 36:362-367
50. Bird TD, Sumi SM, Nemens EJ, et al: Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989; 25:12-25
51. Kennedy AM, Newman SK, Frackowiak RS, et al: Chromosome 14-linked familial Alzheimer's disease: a clinico-pathological study of a single pedigree. Brain 1995; 118:185-205
52. Ezquerra M, Carnero C, Blesa R, et al: A presenilin-1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures. Neurology 1999; 52:566-570
53. Houlden H, Crook R, Dolan RJ, et al: A novel presenilin mutation (M233V) causing very-early-onset Alzheimer's disease with Lewy bodies. Neurosci Lett 2001; 313:93-95
54. Mayeux R, Stern Y, Spanton S: Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35:453-461
55. Mullan M, Houlden H, Crawford F, et al: Age of onset in familial early-onset Alzheimer's disease correlates with genetic aetiology. Am J Med Genet 1993; 48:129-130
56. Tedde A, Forleo P, Nacmias B, et al: A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset. Neurology 2000; 55:1590-1591
57. Raux G, Gantier R, Thomas-Anterion C, et al: Dementia with prominent frontotemporal features associated with L113P presenilin-1 mutation. Neurology 2000; 55:1577-1578
58. Amtul Z, Lewis PA, Piper S, et al: A presenilin-1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiol Dis 2002; 9:269-273
59. Finckh U, Alberici A, Antoniazzi M, et al: Variable expression of familial Alzheimer disease associated with presenilin-2 mutation M2391. Neurology 2000; 54:2006-2008
60. Bird TD, Levy-Lahad E, Poorkaj P, et al: Wide range in age of onset for Chromosome 1-related familial Alzheimer's disease. Ann Neurol 1996; 40:932-936
61. Ezquerra M, Lleó A, Castellvi M, et al: A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer's disease. Arch Neurol 2003; 60:1149-1151
62. Prihar G, Verkkoniemi A, Perez-Tur J, et al: Alzheimer disease PS-1 exon 9 deletion defined. Nat Med 1999; 5:1090
63. Sodeyama N, Iwata T, Ishikawa K, et al: Very-early-onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin-1 mutation (Phe237Ile). J Neurol Neurosurg Psychiatry 2001; 71:556-557
64. Steiner H, Revesz T, Neumann M, et al: A pathogenic presenilin-1 deletion causes aberrant ABeta42 production in the absence of congophilic amyloid plaques. J Biol Chem 2001; 276:7233-7239
65. O'Riordan S, McMonagle P, Janssen JC, et al: Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology 2002; 59:1108-1110
66. Taddei K, Kwok JB, Kril JJ, et al: Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very-early-onset Alzheimer's disease. Neuroreport 1998; 9:3335-3339
67. Matsubara-Tsutsui M, Yasuda M, Yamagata H, et al: Molecular evidence of presenilin-1 mutation in familial early-onset dementia. Am J Med Genet 2002; 114:292-298
68. Assini A, Terreni L, Borghi R, et al: Pure spastic paraparesis associated with a novel presenilin-1 R278K mutation. Neurology 2003; 60:150-151
69. Verkkoniemi A, Somer M, Rinne JO, et al: Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology 2000; 54:1103-1109
70. Verkkoniemi A, Kalimo H, Paetau A, et al: Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol 2001; 60:483-492
71. Tabira T, Chui DH, Nakayama H, et al: Alzheimer's disease with spastic paresis and cotton wool-type plaques. J Neurosci Res 2002; 70:367-372
72. Vidal R, Frangione B, Rostagno A, et al: A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999; 399:776-781
73. Gomez-Isla T, Wasco W, Pettingell WP, et al: A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol 1997; 41:809-813
74. Mann DM, Iwatsubo T, Cairns NJ, et al: Amyloid beta protein (ABeta) deposition in Chromosome 14-linked Alzheimer's disease: predominance of ABeta42(43). Ann Neurol 1996; 40:149-156
75. Mann DM, Pickering-Brown SM, Takeuchi A, et al: Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol 2001; 158:2165-2175
76. Lemere CA, Lopera F, Kosik KS, et al: The E280A presenilin-1 Alzheimer mutation produces increased ABeta 42 deposition and severe cerebellar pathology. Nat Med 1996; 2:1146-1150
77. McNamara MJ, Gomez-Isla T, Hyman BT: Apolipoprotein-E genotype and deposits of ABeta40 and ABeta42 in Alzheimer disease. Arch Neurol 1998; 55:1001-1004
78. Lippa CF, Fujiwara H, Mann DM, et al: Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998; 153:1365-1370
79. Lippa CF, Schmidt ML, Lee VM, et al: Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease. Arch Neurol 2001; 58:1817-1820
80. Le TV, Crook R, Hardy J, et al: Cottonwool plaques in non-familial late-onset Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:1051-1061
81. Ikeda M, Sharma V, Sumi SM, et al: The clinical phenotype of two missense mutations in the presenilin-1 gene in Japanese patients. Ann Neurol 1996; 40:912-917
82. De Jonghe C, Cras P, Vanderstichele H, et al: Evidence that ABeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol Dis 1999; 6:280-287
83. Murayama O, Tomita T, Nihonmatsu N, et al: Enhancement of amyloid beta 42 secretion by 28 different presenilin-1 mutations of familial Alzheimer's disease. Neurosci Lett 1999; 265:61-63
84. Xia W, Zhang J, Kholodenko D, et al: Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 1997; 272:7977-7982
85. Borchelt DR, Thinakaran G, Eckman CB, et al: Familial Alzheimer's disease-linked presenilin-1 variants elevate ABeta1-42/1-40 ratio in vitro and in vivo. Neuron 1996; 17:1005-1013
86. Vanderhoeven I, Cras P, Martin JJ, et al: Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143T and G384A mutations. Neurosci Lett 1999; 274:183-186
87. Wolfe MS, Xia W, Ostaszewski BL, et al: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999; 398:513-517
88. Murphy MP, Uljon SN, Fraser PE, et al: Presenilin-1 regulates pharmacologically distinct gamma-secretase activities implications for the role of presenilin in gamma-secretase cleavage. J Biol Chem 2000; 275:26277-26284
89. Iwatsubo T, Odaka A, Suzuki N, et al: Visualization of ABeta 42(43) and ABeta 40 in senile plaques with end-specific ABeta monoclonals: evidence that an initially deposited species is ABeta 42(43). Neuron 1994; 13:45-53
90. Guo Q, Sopher BL, Furukawa K, et al: Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 1997; 17:4212-4222
91. Guo Q, Sebastian L, Sopher BL, et al: Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J Neurochem 1999; 72:1019-1029
92. Katayama T, Imaizumi K, Sato N, et al: Presenilin-1 mutations downregulate the signaling pathway of the unfolded-protein response. Nat Cell Biol 1999; 1:479-485
93. Milhavet O, Martindale JL, Camandola S, et al: Involvement of Gadd153 in the pathogenic action of presenilin-1 mutations. J Neurochem 2002; 83:673-681
94. Sato N, Urano F, Yoon Leem J, et al: Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat Cell Biol 2000; 2:863-870
95. Siman R, Flood DG, Thinakaran G, et al: Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation. J Biol Chem 2001; 276:44736-44743
96. Kimberly WT, LaVoie MJ, Ostaszewski BL, et al: Gamma-secretase is a membrane protein complex composed of presenilin, nicastrin, aph-1, and pen-2. Proc Natl Acad Sci U S A 2003; (in press)
97. Yu G, Nishimura M, Arawaka S, et al: Nicastrin modulates presenilin-mediated Notch/glp-1 signal transduction and beta-APP processing. Nature 2000; 407:48-54
98. Cao X, Sudhof TC: A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001; 293:115-120
99. Gao Y, Pimplikar SW: The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci U S A 2001; 98:14979-14984
100. Kinoshita A, Whelan CM, Smith CJ, et al: Direct visualization of the gamma-secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J Neurochem 2002; 82:839-847
101. Cupers P, Orlans I, Craessaerts K, et al: The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J Neurochem 2001; 78:1168-1178
102. Artavanis-Tsanokas S, Rand MD, Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 1999; 284:770-776
103. Fortini ME: Gamma-secretase-mediated proteolysis in cell-surface-receptor signaling. Nat Rev Neurosci 2002; 3:673-684
104. Berezovska O, McLean P, Knowles R, et al: Notch1 inhibits neurite outgrowth in postmitotic primary neurons. Neuroscience 1999; 93:433-439
105. Berezovska O, Xia MQ, Hyman BT: Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease. J Neuropathol Exp Neurol 1998; 57:738-745
106. Jack C, Berezovska O, Wolfe MS, et al: Effect of PS-1 deficiency and an APP gamma-secretase inhibitor on Notchl signaling in primary mammalian neurons. Brain Res Mol Brain Res 2001; 87:166-174
107. Berezovska O, Jack C, McLean P, et al: Aspartate mutations in presenilin and gamma-secretase inhibitors both impair Notch 1 proteolysis and nuclear translocation with relative preservation of Notch 1 signaling. J Neurochem 2000; 75:583-593
108. Levitan D, Greenwald I: Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377:351-354
109. Ponting CP, Hutton M, Nyborg A, et al: Identification of a novel family of presenilin homologues. Hum Mol Genet 2002; 11:1037-1044
110. Murayama O, Honda T, Mercken M, et al: Different effects of Alzheimer-associated mutations of presenilin-1 on its processing. Neurosci Lett 1997; 229:61-64
111. Hutton M, Busfield F, Wragg M, et al: Complete analysis of the presenilin-1 gene in early-onset Alzheimer's disease. Neuroreport 1996; 7:801-805
112. Cruts M, Backhovens H, Wang SY, et al: Molecular genetic analysis of familial early-onset Alzheimer's disease linked to Chromosome 14q24.3. Hum Mol Genet 1995; 4:2363-2371
113. Martin JJ, Gheuens J, Bruyland M, et al: Early-onset Alzheimer's disease in two large Belgian families. Neurology 1991; 41:62-68
114. Alzheimer's Disease Collaborative Group: The structure of the presenilin-1 (S182) gene and identification of six novel mutations in early-onset AD families. Nat Genet 1995; 11:219-222
115. Sorbi S, Nacmias B, Forleo P, et al: Missense mutations of S182 gene in Italian families with early-onset Alzheimer's disease. Lancet 1995; 346:439-440
116. Ezquerra M, Carnero C, Blesa R, et al: A novel presenilin-1 mutation (Leu166Arg) associated with early-onset Alzheimer disease. Arch Neurol 2000; 57:485-488
117. Harvey RJ, Ellison D, Hardy J, et al: Chromosome-14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine > serine (L250S) substitution at codon 250 of the presenilin-1 gene. J Neurol Neurosurg Psychiatry 1998; 64:44-49
118. Chapman J, Asherov A, Wang N, et al: Familial Alzheimer's disease associated with S182 codon 286 mutation. Lancet 1995; 346:1040
119. Vassar R, Citron M: ABeta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron 2000; 27:419-422
120. Lammich S, Okochi M, Takeda M, et al: Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an ABeta-like peptide. J Biol Chem 2002; 277:44754-44759
121. Baki L, Marambaud P, Efthiniiopoulos S, et al: Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc Natl Acad Sci U S A 2001; 98:2381-2386
122. Marambaud P, Shioi J, Serban G, et al: A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002; 21:1948-1956
123. Ni CY, Murphy MP, Golde TE, et al: Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294:2179-2181
124. Lee HJ, Jung KM, Huang YZ, et al: Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J Biol Chem 2002; 277:6318-6323
125. May P, Reddy YK, Herz J: Proteolytic processing of low-density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem 2002; 277:18736-18743
126. Kim DY, Ingano LA, Kovacs DM: Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. J Biol Chem 2002; 277:49976-49981
127. De Strooper B, Annaert W, Cupers P, et al: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999; 398:518-522